Drugs / Fluarix™tetra Syringe Inj.
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02658409 Comparator | Nov 2015 | influenza | Green Cross Corporation | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluarixtetra Syringe Inj. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02658409 ↗ |
| Modality | Vaccine | “quadrivalent influenza vaccine” NCT02658409 ↗ |
| Route | Intramuscular | “0.5ml, intramuscular, a single dosing at Day 1” NCT02658409 ↗ |